News

ANAB Stock: Berger Montague Investigates Securities Fraud Class Action Claims Against AnaptysBio, Inc. (NASDAQ: ANAB); Lead Plaintiff Deadline is May 26, 2020

Berger Montague is investigating securities fraud claims against AnaptysBio, Inc. on behalf of all purchasers of AnaptysBio common stock (NASDAQ: ANAB) between October 10, 2017 and November 7, 2019.

  • March 31, 2020
  • Securities & Investor Protection
  • Read More >

CRON Stock: Berger Montague Investigates Securities Fraud Class Action Claims Against Cronos Group, Inc. (NASDAQ: CRON); Lead Plaintiff Deadline is May 11, 2020

Berger Montague is investigating securities fraud claims against Cronos Group, Inc. on behalf of all purchasers of Cronos common stock (NASDAQ: CRON) between May 9, 2019 and March 2, 2020.

  • March 27, 2020
  • Securities & Investor Protection
  • Read More >

AAN Stock: Berger Montague Investigates Securities Fraud Class Action Claims Against Aaron’s, Inc. (NYSE: AAN); Lead Plaintiff Deadline is April 28, 2020

Berger Montague is investigating securities fraud claims against Aaron’s, Inc. on behalf of all purchasers of Aaron’s common stock (NYSE: AAN) between March 2, 2018 and February 19, 2020.

  • March 24, 2020
  • Securities & Investor Protection
  • Read More >

ALGN Stock: Berger Montague Investigates Securities Fraud Class Action Claims Against Align Technology, Inc. (NASDAQ: ALGN); Lead Plaintiff Deadline is May 1, 2020

Berger Montague is investigating securities fraud claims against Align Technology, Inc. on behalf of all purchasers of Align common stock (NASDAQ: ALGN) between April 24, 2019 and July 24, 2019.

NCLH Stock: Berger Montague Investigates Securities Fraud Class Action Claims Against Norwegian Cruise Line Holdings Ltd. (NASDAQ: NCLH); Lead Plaintiff Deadline is May 11, 2020

Berger Montague is investigating securities fraud claims against Norwegian Cruise Line Holdings Ltd. on behalf of all purchasers of Norwegian common stock (NASDAQ: NCLH) between February 20, 2020 and March 12, 2020.

INO Stock: Berger Montague Investigates Securities Fraud Class Action Claims Against Inovio Pharmaceuticals, Inc. (NASDAQ: INO); Lead Plaintiff Deadline is May 12, 2020

Berger Montague is investigating securities fraud claims against Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) on behalf of all purchasers of Inovio common stock (NASDAQ: INO) between February 14, 2020 and March 9, 2020 (“Class Period”).

  • March 13, 2020
  • Securities & Investor Protection
  • Read More >

Berger Montague to Represent New York Employers in Workers’ Compensation Insurance Actions Against Applied Underwriters and Continental Indemnity Company

Berger Montague, one of the nation’s leading litigation firms, is representing New York-based employers who were overcharged for premiums paid on workers’ compensation insurance policies issued by Continental Indemnity Company, an Applied Underwriters subsidiary, under the EquityComp, SolutionOne, or JumboGC programs at any time since 2008.

Berger Montague to Represent California Employers in Workers’ Compensation Insurance Actions Against Applied Underwriters and California Insurance Company

Berger Montague is representing California-based employers who were overcharged for premiums paid on workers’ compensation insurance policies issued by California Insurance Company, an Applied Underwriters subsidiary, under the EquityComp, SolutionOne, or JumboGC programs at any time since 2008.

Qui Tam Lawsuit to Proceed Against Hospice Care Provider Care Alternatives

Berger Montague is pleased to announce that the Third Circuit has overturned a previous ruling and will allow a qui tam case brought by Managing Shareholder Sherrie R. Savett, Shareholder Russell D. Paul, and co-counsel to continue against Care Alternatives.

Shanon J. Carson of Berger Montague Named Co-Lead Counsel in Allergan BIOCELL Textured Breast Implant Litigation

The national plaintiffs’ law firm Berger Montague is pleased to announce that one of its Managing Shareholders, Shanon J. Carson, has been appointed by Judge Brian R. Martinotti of the United States District Court for the District of New Jersey to serve as Co-Lead Counsel in the Allergan BIOCELL Textured Breast Implant Products Liability Litigation, No. 2:19-md-02921, MDL No. 2921 (D.N.J.).

  • February 26, 2020
  • Defective Drugs & Medical Devices
  • Read More >
Go to page: 1 2 3 9

Request A Free Consultation